What is Orphan Pharmacy Services?
Orphan Pharmacy Services, operating as Evergreen Pharma Services, is a dedicated Clinical Trial Services and Support Organization. It partners with academic institutions and manufacturers to enhance patient and provider support throughout clinical trials and beyond.
The company's core competencies lie in managing HUB operations, overseeing clinical trials, and facilitating expanded access programs. It also develops customized programs tailored to specific patient demographics, with a particular focus on the rare disease population. Services include CRO management, data reporting, patient assistance programs, and compassionate care management, all designed to ensure a smooth transition from clinical trial phases to commercial product availability.
How much funding has Orphan Pharmacy Services raised?
Orphan Pharmacy Services has raised a total of $82K across 1 funding round:
Debt
$82K
Debt (2021): $82K with participation from PPP
What's next for Orphan Pharmacy Services?
With the recent influx of substantial expansion capital, Orphan Pharmacy Services is poised for significant scaling and operational enhancement. The company's strategic focus on rare diseases and comprehensive support services, including HUB operations and patient assistance, positions it to capitalize on the growing demand for specialized clinical trial management.
Future developments are likely to involve expanding its service offerings, potentially through further strategic partnerships or acquisitions, and deepening its technological capabilities in data reporting and CRO management. This funding round is expected to fuel its mission to bridge the gap between clinical research and commercialization for rare disease treatments, reinforcing its role as a critical player in the pharmaceutical support ecosystem.
